• OPEN AN ACCOUNT
Indian Indices
Sensex
82,970.59 -763.66
( -0.91%)
Global Indices
Nasdaq
49,673.83 119.63
(0.24%)
Dow Jones
6,900.77 36.55
(0.53%)
Hang Seng
57,519.13 375.29
(0.66%)
Nikkei 225
10,698.60 142.43
(1.35%)
Forex
USD-INR
90.69 0.00
(0.00%)
EUR-INR
107.37 -0.18
(-0.16%)
GBP-INR
123.10 -0.58
(-0.47%)
JPY-INR
0.59 0.00
(0.08%)

EQUITY - MARKET SCREENER

BIL Vyapar Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
500059
INE071A01013
-59.8621046
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BILVYAPAR
0
22.27
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

genpharmasec limited
Balaji Amines soars after Maharashtra incentives approval
Jan 08,2026
The rally followed the company’s disclosure that the Directorate of Industries, Government of Maharashtra, has granted incentives for the expansion of Unit IV at Chincholi MIDC in Solapur under the Mega Projects category.

Under the scheme, Balaji Amines is eligible for Industrial Promotion Subsidy of up to Rs 258 crore. The subsidy is linked to 50% of the SGST payable on sales of eligible finished products within Maharashtra.

The company will also benefit from electricity duty exemption. It has been granted a 100% waiver on stamp duty as well.

These incentives will be available for seven years. The period runs from 1 January 2024 to 31 December 2030.

Balaji Amines is engaged in the activity of manufacture and sale of Aliphatic Amines, speciality chemicals and its derivatives.

On a consolidated basis, net profit of Balaji Amines declined 15.67% to Rs 34.56 crore while net sales declined 1.82% to Rs 340.55 crore in Q2 September 2025 over Q2 September 2024.